18
Participants
Start Date
May 1, 2019
Primary Completion Date
March 23, 2021
Study Completion Date
August 13, 2023
Avelumab
"Induction phase:~* once weekly for weeks 1-6,~* once every 2 weeks at week 8, 10, and 12~Maintenance phase:~* Once every week for weeks 1-3~* Once every 2 weeks starting at week 5, until the next BCG treatment"
BCG
"Induction phase (cycle 1):~• Once weekly for weeks 1-6~Maintenance phase (Month 3, 6, and 12):~• Once weekly for 3 weeks"
Stephenson Cancer Center, Oklahoma City
Collaborators (1)
EMD Serono
INDUSTRY
University of Oklahoma
OTHER